BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,299,572 | -12.5% | 140,423 | +5.7% | 0.90% | -15.1% |
| Q2 2023 | $6,053,876 | +22.6% | 132,877 | +9.1% | 1.07% | +12.4% |
| Q1 2023 | $4,939,275 | +391.9% | 121,777 | +518.1% | 0.95% | +369.3% |
| Q4 2022 | $1,004,211 | +0.7% | 19,702 | +6.5% | 0.20% | -4.7% |
| Q3 2022 | $997,000 | -16.1% | 18,502 | 0.0% | 0.21% | -9.8% |
| Q2 2022 | $1,188,000 | -17.2% | 18,502 | 0.0% | 0.24% | -8.9% |
| Q1 2022 | $1,435,000 | -9.5% | 18,502 | +0.2% | 0.26% | -8.5% |
| Q4 2021 | $1,585,000 | +6.7% | 18,467 | 0.0% | 0.28% | -4.7% |
| Q3 2021 | $1,485,000 | -3.0% | 18,467 | -2.9% | 0.30% | +1.0% |
| Q2 2021 | $1,531,000 | -4.6% | 19,017 | 0.0% | 0.29% | -11.7% |
| Q1 2021 | $1,604,000 | +5.9% | 19,017 | +0.8% | 0.33% | -4.3% |
| Q4 2020 | $1,514,000 | -1.2% | 18,867 | -1.0% | 0.35% | -12.4% |
| Q3 2020 | $1,533,000 | -6.6% | 19,067 | 0.0% | 0.40% | -11.0% |
| Q2 2020 | $1,642,000 | +3.6% | 19,067 | -2.3% | 0.44% | -11.5% |
| Q1 2020 | $1,585,000 | -3.4% | 19,517 | -0.5% | 0.50% | +17.8% |
| Q4 2019 | $1,640,000 | -3.9% | 19,617 | +0.5% | 0.43% | -9.7% |
| Q3 2019 | $1,707,000 | +6.4% | 19,517 | -0.4% | 0.47% | +6.1% |
| Q2 2019 | $1,605,000 | -1.0% | 19,592 | -1.8% | 0.45% | -3.5% |
| Q1 2019 | $1,621,000 | -99.9% | 19,942 | -2.3% | 0.46% | +6.9% |
| Q4 2018 | $1,343,452,000 | +85307.0% | 20,411 | 0.0% | 0.43% | -4.4% |
| Q3 2018 | $1,573,000 | -0.5% | 20,411 | -4.7% | 0.45% | -6.2% |
| Q2 2018 | $1,581,000 | +13.5% | 21,411 | 0.0% | 0.48% | +5.9% |
| Q1 2018 | $1,393,000 | +0.4% | 21,411 | -0.3% | 0.46% | +0.4% |
| Q4 2017 | $1,388,000 | -16.7% | 21,467 | -19.2% | 0.45% | -22.7% |
| Q3 2017 | $1,666,000 | +2.5% | 26,554 | -1.1% | 0.59% | -2.3% |
| Q2 2017 | $1,625,000 | +16.7% | 26,838 | +0.0% | 0.60% | +14.3% |
| Q1 2017 | $1,392,000 | +17.5% | 26,837 | +0.4% | 0.52% | +12.9% |
| Q4 2016 | $1,185,000 | -8.6% | 26,736 | -1.9% | 0.46% | -10.7% |
| Q3 2016 | $1,297,000 | +5.7% | 27,244 | +0.4% | 0.52% | +3.2% |
| Q2 2016 | $1,227,000 | +13.0% | 27,143 | +2.7% | 0.50% | +6.8% |
| Q1 2016 | $1,086,000 | +19.3% | 26,442 | +10.9% | 0.47% | +11.3% |
| Q4 2015 | $910,000 | +10.2% | 23,840 | -5.2% | 0.42% | +2.4% |
| Q3 2015 | $826,000 | -38.5% | 25,139 | +31.0% | 0.42% | -34.6% |
| Q2 2015 | $1,342,000 | +49.4% | 19,188 | +46.4% | 0.64% | +44.6% |
| Q1 2015 | $898,000 | +43.7% | 13,106 | +53.6% | 0.44% | +40.7% |
| Q4 2014 | $625,000 | – | 8,531 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |